ʹÓõҲ¨-ÆÕάÀ±ÜÔÐÕë1Äê±ÜÔÐЧ¹û¹Û²ì
×÷ÕߣºÂÞ½ð¾Õ ÎâÑàƼ ÕÅ´úÕê
µ¥Î»£ºÂÞ½ð¾Õ ÓÀ°²Êмƻ®ÉúÓý·þÎñÕ¾£»ÎâÑàƼ ÕÅ´úÕê ÓÀ°²ÊÐÁ¢Ò½Ôº
¹Ø¼ü´Ê£º
Ϊ¹Û²ìµÒ²¨ Ϊ¹Û²ìµÒ²¨-ÆÕάÀ(DMPA)³¤Ð§±ÜÔÐÕë¶ÔÓýÁ举ٵıÜÔÐЧ¹û£¬ÎÒÃÇÓÚ1996Äê10ÔÂÆðÁÙ´²Ó¦ÓÃDMPA¹²¼Æ100Àý£¬¹Û²ì½á¹û±¨¸æÈçÏ¡£
1 ¶ÔÏóÓë·½·¨
1.1 ¶ÔÏó Ñ¡Ôñ22¡«35Ë꽡¿µÓÐÉúÓýÁ¦£¬ÒÑÉúÓýÒ»º¢£¬¼´ÍùÔ¾Õý³££¬Ö¾Ô¸Ö»²ÉÓÃDMPA£¬²¢ÄÜ׼ȷ¼Ç¼Ô¾¿¨£¬¶¨ÆÚÀ´Õ¾Ëæ·ÃÕß¡£²¸È鸾ŮÔÚ²úºó42 dÖÁ1ÄêÄÚ£¬ÅųýÁ÷²úºóδת¾¼°·ÖÃäºóδת¾Ò²²»²¸ÈéÕß¡£ÓÃҩǰѯÎʲ¡Ê·£¬Ìå¼ì£¬Åųý½û¼ÉÖ¢£¬ÈëÑ¡ÕßÓÃҩǰ˵Ã÷Ò©ÎïÌØÐÔ£¬±ÜÔÐЧ¹û¼°¿ÉÄÜ·¢ÉúµÄ¸±·´Ó¦¡£Ö¸µ¼Ô¾¿¨¼Ç¼·½·¨£¬×¢Éäʱ¼ä¼°Ëæ·Ã×¢ÒâÊÂÏî¡£
, °ÙÄ´Ò½Ò©
1.2 ·½·¨ DMPAÿ֧º¬´×Ëá¼×ÔÐͪ150 mg£¬É¼¡×¢¡£Ã¿ÀýÓÚÔ¾À´³±µÚ1¡«5 d»ò·ÖÃäºó6¡«8ÖÜÃÅÕï¼ì²éʱÒÔ¼°ÈËÁ÷ºóµ±Ìì×¢ÉäµÚÒ»Õ룬ÒÔºóÿ3¸öÔÂ(11¡«14ÖÜ)1´Î¡£¼ä¸ô14ÖÜÒÔÉÏ×¢ÉäÓ¦ÅųýÔçÔС£
2 ½á¹û
100ÀýµÄ»ù±¾ÌØÕ÷¼°Í£ÓÃÔÒò¡¢¸±·´Ó¦(¼û±í1¡¢2¡¢3)¡£±ÜÔÐЧ¹û Ó¦ÓÃDMPA¹²¼ÆʹÓÃ1136¸¾Å®£¬ÎÞ1ÀýÒâÍâÈÑÉï¡£
±í1 100 Àý »ù ±¾ ÌØ Õ÷
²»²¸Èé
²¸Èé
ÀýÊý
58
42
, °ÙÄ´Ò½Ò©
ÄêÁä(Ëê)
28.6+2.7
25.8+1.2
ÌåÖØ(kg)
52.8+5.3
52.5+5.5
ÌåÖØÖ¸Êý(kg/m2)
20.8+2.3
21.7+1.8
ÒÔÍù6¸öÔÂÓйýÁ÷²ú
25
0
, http://www.100md.com
δʹÓñÜÔз½·¨
2
42
±í2 DMPAʹÓÃ1ÄêÍ£ÓÃÔÒò Í£ÓÃÔÒò
1Õëºó
2Õëºó
3Õëºó
4Õëºó
³öѪ¶à²»¹æÔò³öѪ
1
2
4
4
, http://www.100md.com
±Õ¾
0
1
1
1
ÆäËüҽѧÔÒò
0
0
1
1
±í3 DMPA×¢Éä1ÄêÆÚÖ÷Ë߸±·´Ó¦
3¸öÔÂ
6¸öÔÂ
, http://www.100md.com
9¸öÔÂ
12¸öÔÂ
¶ÔÏóÀýÊý
100
99
97
94
ÎÞÖ÷Ëß
68
70
59
67
ÓÐÖ÷Ëß
, °ÙÄ´Ò½Ò© 32
30
38
27
³öѪÁ¿¶à¾ÆÚ³¤
13
8
6
2
²»¹æÔò³öѪµãµÎ³öѪ
10
11
17
5
, °ÙÄ´Ò½Ò©
±Õ¾
3
10
13
17
Ñ£ÔÎÍ·Í´
2
1
1
2
ÆäËüҽѧÔÒò
0
0
1
, http://www.100md.com
1
3 ÌÖ ÂÛ
3.1 ´¿Ôм¤ËرÜÔÐÕëDMPAÒѱ»´óÁ¿ÁÙ´²Ñо¿Ö¤ÊµÎª°²È«¡¢¸ßЧ¡¢Ê¹Ó÷½±ãµÄ³¤Ð§±ÜÔз½·¨£¬²¢ÒÑÔÚ¹úÍâ¹ãΪӦÓÃ[1]¡£µ«ÓëËùÓд¿Ôм¤ËرÜÔмÁÒ»Ñù£¬ËüÃÇÔÚʹÓÃʱ±Õ¾ºÍÔ¾ÎÉÂÒ·¢ÉúÂʸߣ¬±¾¹Û²ìʹÓÃDMPA100ÀýÓÃÕë1Ä꣬ÎÞ1ÀýÒâÍâÈÑÉͣÕëÖ÷ÒªÔÒòΪÔ¾Òì³££¬ÒÔ²»¹æÔò³öѪΪ¶à¡£
3.2 ʹÓÃDMPA²»ÂÛÓзñ²¸È飬Ö÷Ëß¾ùÒÔÔ¾ÎÊÌâΪÖ÷£¬ÓÈÆäÒÔ³öѪÁ¿¶à£¬¾ÆÚ³¤£¬²»¹æÔò³öѪ£¬µãµÎ³öѪΪ¶à£¬ÒÔÉϲ»¹æÔò³öѪËæʱ¼äµÄÍÆÒƳÊÃ÷ÏÔϽµÇ÷ÊÆ¡£±Õ¾Çé¿öÈ´Ïà·´£¬Ëæʱ¼äµÄÍÆÒƳÊÃ÷ÏÔÉÏÉýÇ÷ÊÆ¡£ÓÃÕëÆÚ¼äδ¼ûÃ÷ÏÔÆäËüÑÏÖظ±·´Ó¦¡£
3.3 42Àý²¸Èé¶ÔÏóÓë58Àý·Ç²¸Èé¶ÔÏóÔÚÖ÷Ëß³öѪÁ¿¶à£¬²»¹æÔò³öѪ£¬±Õ¾µÈÏîÄ¿±È½ÏÎÞÏÔÖøÐÔ²îÒì(P>0.05)¡£ËßÈéÖ¼õÉÙ½öΪ2Àý£¬ÉÐÄÑÈ·¶¨ÓëÓÃÒ©Óйء£¾Ý±¾×é×ÊÁÏ·ÖÎö£¬DMPA¶ÔÈéÖ»ù±¾ÎÞÓ°Ïì¡£ÔÚ²úºó»Ö¸´ÅÅÂÑǰʹÓÃDMPA¿ÉÒÔ×÷Ϊ³¤ÆÚʹÓõķ½·¨£¬»ò×÷ΪÆäËü½ÚÓý´ëÊ©Ñ¡ÔñÇ°µÄ¹ý¶É·½·¨£¬¿ÉÓÐЧµØ¿ØÖƲ¸ÈéÆÚµÄÈ˹¤Á÷²ú£¬±£ÕÏĸӤ½¡¿µ¡£²Î¿¼ÎÄÏ×
1.Mishell DR£ºLong-acting contraceptive steroids£¬postcoital contraceptives and antiprogestions.In£ºMishell DR Jr.Davajan V.LoboRA£¬eds.Infertility£¬Contraception.and Reproductive Endocrinology.Bosston£ºBlackwell Scientific Publications.1991£»872, http://www.100md.com
µ¥Î»£ºÂÞ½ð¾Õ ÓÀ°²Êмƻ®ÉúÓý·þÎñÕ¾£»ÎâÑàƼ ÕÅ´úÕê ÓÀ°²ÊÐÁ¢Ò½Ôº
¹Ø¼ü´Ê£º
Ϊ¹Û²ìµÒ²¨ Ϊ¹Û²ìµÒ²¨-ÆÕάÀ(DMPA)³¤Ð§±ÜÔÐÕë¶ÔÓýÁ举ٵıÜÔÐЧ¹û£¬ÎÒÃÇÓÚ1996Äê10ÔÂÆðÁÙ´²Ó¦ÓÃDMPA¹²¼Æ100Àý£¬¹Û²ì½á¹û±¨¸æÈçÏ¡£
1 ¶ÔÏóÓë·½·¨
1.1 ¶ÔÏó Ñ¡Ôñ22¡«35Ë꽡¿µÓÐÉúÓýÁ¦£¬ÒÑÉúÓýÒ»º¢£¬¼´ÍùÔ¾Õý³££¬Ö¾Ô¸Ö»²ÉÓÃDMPA£¬²¢ÄÜ׼ȷ¼Ç¼Ô¾¿¨£¬¶¨ÆÚÀ´Õ¾Ëæ·ÃÕß¡£²¸È鸾ŮÔÚ²úºó42 dÖÁ1ÄêÄÚ£¬ÅųýÁ÷²úºóδת¾¼°·ÖÃäºóδת¾Ò²²»²¸ÈéÕß¡£ÓÃҩǰѯÎʲ¡Ê·£¬Ìå¼ì£¬Åųý½û¼ÉÖ¢£¬ÈëÑ¡ÕßÓÃҩǰ˵Ã÷Ò©ÎïÌØÐÔ£¬±ÜÔÐЧ¹û¼°¿ÉÄÜ·¢ÉúµÄ¸±·´Ó¦¡£Ö¸µ¼Ô¾¿¨¼Ç¼·½·¨£¬×¢Éäʱ¼ä¼°Ëæ·Ã×¢ÒâÊÂÏî¡£
, °ÙÄ´Ò½Ò©
1.2 ·½·¨ DMPAÿ֧º¬´×Ëá¼×ÔÐͪ150 mg£¬É¼¡×¢¡£Ã¿ÀýÓÚÔ¾À´³±µÚ1¡«5 d»ò·ÖÃäºó6¡«8ÖÜÃÅÕï¼ì²éʱÒÔ¼°ÈËÁ÷ºóµ±Ìì×¢ÉäµÚÒ»Õ룬ÒÔºóÿ3¸öÔÂ(11¡«14ÖÜ)1´Î¡£¼ä¸ô14ÖÜÒÔÉÏ×¢ÉäÓ¦ÅųýÔçÔС£
2 ½á¹û
100ÀýµÄ»ù±¾ÌØÕ÷¼°Í£ÓÃÔÒò¡¢¸±·´Ó¦(¼û±í1¡¢2¡¢3)¡£±ÜÔÐЧ¹û Ó¦ÓÃDMPA¹²¼ÆʹÓÃ1136¸¾Å®£¬ÎÞ1ÀýÒâÍâÈÑÉï¡£
±í1 100 Àý »ù ±¾ ÌØ Õ÷
²»²¸Èé
²¸Èé
ÀýÊý
58
42
, °ÙÄ´Ò½Ò©
ÄêÁä(Ëê)
28.6+2.7
25.8+1.2
ÌåÖØ(kg)
52.8+5.3
52.5+5.5
ÌåÖØÖ¸Êý(kg/m2)
20.8+2.3
21.7+1.8
ÒÔÍù6¸öÔÂÓйýÁ÷²ú
25
0
, http://www.100md.com
δʹÓñÜÔз½·¨
2
42
±í2 DMPAʹÓÃ1ÄêÍ£ÓÃÔÒò Í£ÓÃÔÒò
1Õëºó
2Õëºó
3Õëºó
4Õëºó
³öѪ¶à²»¹æÔò³öѪ
1
2
4
4
, http://www.100md.com
±Õ¾
0
1
1
1
ÆäËüҽѧÔÒò
0
0
1
1
±í3 DMPA×¢Éä1ÄêÆÚÖ÷Ë߸±·´Ó¦
3¸öÔÂ
6¸öÔÂ
, http://www.100md.com
9¸öÔÂ
12¸öÔÂ
¶ÔÏóÀýÊý
100
99
97
94
ÎÞÖ÷Ëß
68
70
59
67
ÓÐÖ÷Ëß
, °ÙÄ´Ò½Ò© 32
30
38
27
³öѪÁ¿¶à¾ÆÚ³¤
13
8
6
2
²»¹æÔò³öѪµãµÎ³öѪ
10
11
17
5
, °ÙÄ´Ò½Ò©
±Õ¾
3
10
13
17
Ñ£ÔÎÍ·Í´
2
1
1
2
ÆäËüҽѧÔÒò
0
0
1
, http://www.100md.com
1
3 ÌÖ ÂÛ
3.1 ´¿Ôм¤ËرÜÔÐÕëDMPAÒѱ»´óÁ¿ÁÙ´²Ñо¿Ö¤ÊµÎª°²È«¡¢¸ßЧ¡¢Ê¹Ó÷½±ãµÄ³¤Ð§±ÜÔз½·¨£¬²¢ÒÑÔÚ¹úÍâ¹ãΪӦÓÃ[1]¡£µ«ÓëËùÓд¿Ôм¤ËرÜÔмÁÒ»Ñù£¬ËüÃÇÔÚʹÓÃʱ±Õ¾ºÍÔ¾ÎÉÂÒ·¢ÉúÂʸߣ¬±¾¹Û²ìʹÓÃDMPA100ÀýÓÃÕë1Ä꣬ÎÞ1ÀýÒâÍâÈÑÉͣÕëÖ÷ÒªÔÒòΪÔ¾Òì³££¬ÒÔ²»¹æÔò³öѪΪ¶à¡£
3.2 ʹÓÃDMPA²»ÂÛÓзñ²¸È飬Ö÷Ëß¾ùÒÔÔ¾ÎÊÌâΪÖ÷£¬ÓÈÆäÒÔ³öѪÁ¿¶à£¬¾ÆÚ³¤£¬²»¹æÔò³öѪ£¬µãµÎ³öѪΪ¶à£¬ÒÔÉϲ»¹æÔò³öѪËæʱ¼äµÄÍÆÒƳÊÃ÷ÏÔϽµÇ÷ÊÆ¡£±Õ¾Çé¿öÈ´Ïà·´£¬Ëæʱ¼äµÄÍÆÒƳÊÃ÷ÏÔÉÏÉýÇ÷ÊÆ¡£ÓÃÕëÆÚ¼äδ¼ûÃ÷ÏÔÆäËüÑÏÖظ±·´Ó¦¡£
3.3 42Àý²¸Èé¶ÔÏóÓë58Àý·Ç²¸Èé¶ÔÏóÔÚÖ÷Ëß³öѪÁ¿¶à£¬²»¹æÔò³öѪ£¬±Õ¾µÈÏîÄ¿±È½ÏÎÞÏÔÖøÐÔ²îÒì(P>0.05)¡£ËßÈéÖ¼õÉÙ½öΪ2Àý£¬ÉÐÄÑÈ·¶¨ÓëÓÃÒ©Óйء£¾Ý±¾×é×ÊÁÏ·ÖÎö£¬DMPA¶ÔÈéÖ»ù±¾ÎÞÓ°Ïì¡£ÔÚ²úºó»Ö¸´ÅÅÂÑǰʹÓÃDMPA¿ÉÒÔ×÷Ϊ³¤ÆÚʹÓõķ½·¨£¬»ò×÷ΪÆäËü½ÚÓý´ëÊ©Ñ¡ÔñÇ°µÄ¹ý¶É·½·¨£¬¿ÉÓÐЧµØ¿ØÖƲ¸ÈéÆÚµÄÈ˹¤Á÷²ú£¬±£ÕÏĸӤ½¡¿µ¡£²Î¿¼ÎÄÏ×
1.Mishell DR£ºLong-acting contraceptive steroids£¬postcoital contraceptives and antiprogestions.In£ºMishell DR Jr.Davajan V.LoboRA£¬eds.Infertility£¬Contraception.and Reproductive Endocrinology.Bosston£ºBlackwell Scientific Publications.1991£»872, http://www.100md.com